MedPath

Neurophysiological Assessment of Healthy and Impaired Human Lower Urinary Tract Function

Not Applicable
Completed
Conditions
Lower Urinary Tract Symptoms
Registration Number
NCT02272309
Lead Sponsor
Ulrich Mehnert
Brief Summary

Study part 1 will consist of sensory evoked cortical potential (SEP) measurements of the lower urinary tract (LUT) in healthy subjects using different stimulation frequencies from 0.25 to 3Hz to find the most effective frequency in regard to acquisition time for reliable SEP response rates. Study part 2 will consist of a series of consecutive SEP measurements in patients with LUT symptoms during low bladder volume and maximum cystometric capacity to assess reliability of measurements and influence of potential concomitant LUTS treatments.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
124
Inclusion Criteria

healthy volunteers:

  • Written informed consent,
  • good mental and physical health,
  • age >18y,

Patients with LUTS and Patients with LUTS and treatment:

  • Written informed consent,
  • age >18y,
  • prior urodynamic investigation,
  • LUTS since >6months with or without detrusor overactivity
Exclusion Criteria

healthy volunteers:

  • any neurological or urological pathology,
  • current pregnancy or lactation,
  • urinary tract infection,
  • hematuria,
  • any previous pelvic or spine or craniocerebral surgery,
  • any anatomical anomaly of the LUT or genitalia,
  • any metabolic disease,
  • any LUT malignancy,
  • bladder capacity <150mL,
  • SDV at 60mL;

Patients with LUTS and Patients with LUTS and treatment:

  • current pregnancy or lactation,
  • urinary tract infection,
  • gross hematuria

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
N1latency of LUT SEPs2-3 measurements within 4-16 weeks from first exam
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universitätsklinik Balgrist

🇨🇭

Zurich, Switzerland

Universitätsklinik Balgrist
🇨🇭Zurich, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.